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[57] ABSTRACT 
A method for making a biocompatible polymer article using 
a uniform atomic oxygen treatment is disclosed. The sub-
strate may be subsequently optionally grated with a com-
patibilizing compound. Compatibilizing conipounds may 
include proteins, phosphorylcholine groups, platelet adhe-
sion preventing polymers, albumin adhesion promoters, and 
the like. The compatibilized substrate may also have a living 
cell layer adhered thereto. The atomic oxygen is preferably 
produced by a flowing afterglow microwave discharge. 
wherein the substrate resides in a sidearm out of the plasma. 
Also, methods for culturing cells for various purposes using 
the various membranes are disclosed as well. Also disclosed 
are porous organic polymers having a distributed pore 
chemistry (DPC) comprising hydrophilic and hydrophobic 
regions. and a method for making the DPC by exposing the 
polymer to atomic oxygen wherein the rate of hydropbiliza-
tion is greater than the rate of mass loss. 
4 Claims, 1 Drawing Sheet 
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DISTRIBUTED PORE CHEMISTRY IN 
POROUS ORGANIC POLYMERS 
2 
a cell mass. In addition, membranes made by the biocom-
patibilizing method are disclosed, and methods for perform-
ing immunodiagnostic testing using the membranes. Also, 
methods for culturing cells for various purposes using the CROSS-REFERENCE TO RELlITED 
APPLICATIONS 5 various membranes are disclosed. 
The use of polymeric materials for biomedical implants 
and in biotechnical manufacture is an advancing art. Plasma 
discharges have been used to engineer such polymers 
because surface chemistry can be altered without adversely 
This application is a divisional of U.S. Ser'/Appl. No. 
08/254,361, filed Jun. 3, 1994, now U.S. Pat. No. 5,798,261, 
which in turn is a continuation-in-part of U.S. Ser'/Appl. 
Nos. 07/857,901, filed Mar. 26, 1992, now U.S. Pat. Nos. 
5,369,012 and 07/997,265, filed Feb. 23, 1993, now U.S. 
Pat. No. 5,332,551, which in turn is a division of U.S. 
Ser.!Appl. No. 07/894,505, filed Jun. 2, 1992, now U.S. Pat. 
No. 5,215,790, which in turn is a division of U.S. Ser.!Appl. 
No. 07/429,739, filed Oct. 31, 1989, now U.S. Pat. No. 
5,141,806. 
10 affecting bulk properties which make polymeric materials 
useful. However, plasma devices typically do not deliver a 
uniform concentration of the reactive species. Subject to 
complex interactions, non-uniform distribution of plasma 
species may increase manufacturing difficulty and inlpair 
15 quality control. 
ORIGIN OF THE INVENTION 
The invention described herein was made by employee(s) 
of the United States Government and may be manufactured 20 
and used by or for the Government of the United States of 
America for governmental purposes without the payment of 
any royalties thereon or therefor. 
Silicone rubber has long been used in medical devices 
such as surgical inlplants due to desirable properties includ-
ing gas permeability, pliability, degradation resistance, ease 
of fabrication and relatively good biocompatibility. 
However, such materials are not completely inert in the 
body. Recent methods have been sought to inlprove its 
FIELD OF THE INVENTION 
This invention relates to porous organic polymer struc-
tures having a distributed pore chemistry, and particularly to 
distributed pore chemistry polymers having adjacent hydro-
phobic and hydrophilic regions, and preparation of such 
distributed pore chemistry polymers by surface modification 
with gas-phase radicals without substantial mass loss. 
biologic inertness by either surface modffication to increase 
hydrophilicity or bulk modification, i. e. incorporating polar 
groups into the monomer or prepolymer. Tsai, Chi-Chun et 
25 al., in Transactions of the American Society of Artificial 
Internal Organs (ASAlO), vol. XXXIV, (1988) discloses a 
method for increasing the albumin affinity of silicone rubber. 
A vinyl-methyl silicone comonomer was hydroxylated and 
then film coated on a silicone rubber sheet The OH-coated 
BACKGROUND OF THE INVENTION 
30 sheet was grafted with a C16 alkyl chain having a terminal 
acyl group by an esterification reaction catalyzed by 
4-dimethylaminopyridine. Albumin adsorption and retention 
was said to be markedly enhanced for surface OH and C16 
The modification of generally inert solids with gas-phase 35 
radicals such as atomic oxygen and hydroxyl radicals is 
known in the art. In earlier U.S. Pat. Nos. 5,141,806 and 
5,215,790, both to Steven L. Koontz, there is disclosed a 
microporous structure with layered interstitial surface 
treatments, which is prepared by sequentially subjecting a 40 
uniformly pore-surface-treated porous structure to atomic 
oxygen treatment to remove an outer layer of pore surface 
treatment to a generally uniform depth within the porous 
solid, and surface treating the so oxidized region of the 
porous solid with another surface treating agent. The atomic 45 
oxygen/surface treatment steps can be repeated, each suc-
cessive time to a lesser depth within the porous solid, to 
produce a microporous structure having multi-layered pore 
surface chemistries. This structure and preparation method-
ology are disclosed primarily for use with porous substrate 50 
concentrations as low as 5% reaction yield. Tsai, Chi-Chun 
et al., in ASAlO, vol. XXXVI, (1990) discloses use of the 
above albumin adsorbed silicone surfaces as thin 
transparent, biocompatible films for coating the surfaces of 
blood contacting devices. These films are said to retard 
undesired responses, e. g. blood coagulation and activation 
of complement proteins, platelets and white blood cells, 
triggered by exposure of blood stream macromolecules to a 
foreign surface. 
Polymer prostheses have been considered for vascular 
applications. C. Stimpson et al., in Biomaterials, Artificial 
Cells, and Artificial Organs, 17(1), (1989), pp. 31-43 dis-
closes silicone rubber canine aortic prostheses. A uniformly 
microporous prosthesis is made by molding the polymer in 
a template taken from the skeletal structure of a marine life 
form. 
structures which are inert in oxidizing plasmas, such as Durrani et al., in Polymer Surfaces and Interfaces, chapter 
refractory metal oxides like alumina or silica. The surface 10, J Wiley & Sons, (1987), pages 189-200 discloses 
treating agents are primarily organic compounds which are modffication of polymer surfaces with a phosphorylcholine, 
reactive with atomic oxygen plasma so they can be removed for example, to mimic biomembrane surfaces in bioappli-
by exposure thereto. 55 cations. Modifications of this sort are said to reduce foreign 
In our copending application U.S. Ser. No. 07/857,901, surface induced thromboses associated with the use of blood 
filed Mar. 26, 1992, by Koontz, Spaulding and Leger, a contacting devices. 
method for making a biocompatible polymer article using a Rajender Sipehia in Biomaterials, Artificial Cells, and 
uniform atomic oxygen treatment of a polymer substrate is Artificial Organs, 16(5), (1988-89), pp. 955-966 discloses 
disclosed. The substrate may be subsequently optionally 60 immobilizing proteins to polymeric surfaces. Polypropylene 
grafted with a compatibilizing compound, such as proteins, membranes are treated by gaseous oxygen or ammonia 
phosphorylcholine groups, platelet adhesion preventing plasma to add hydroxyl or amino groups to the polymer 
polymers, albumin, adhesion promoters, and the like. The surface. The proteins are then grafted to the surface. 
compatibilized substrate may also have a living cell layer Rajender Sipehia in Biomaterials, Artificial Cells, and Arti-
adhered thereto. Also disclosed are a vascular prosthesis and 65 ficial Organs, 18(3), (1990), pp. 437-446 discloses ammo-
other articles made by the biocompatibilizing method as nia plasma modification of polystyrene petri dishes and 
well as methods for using such biocompatibilized articles in poly(tetrafiuoroethylene) membranes and grafting of pro-
5,935,845 
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teins to the surface. The growth of bovine puhnonary artery 
endothelial cells on the modified surface is enhanced by 
adherence to the grafted proteins. 
In U.S. Pat. No. 4,134,949 to Chen, the surface of a 
contact lens is modified by deposition of a hydrophilic 
polymer under the influence of plasma glow discharge to 
integrally bond the coating to the surface of a hydrophobic 
lens. 
Elizabeth G. Nabel et aI., in Science, vol. 244, Jun. 16, 
1989, pp. 1342-1345 discloses a transplant of endothelial 
cells expressing a recombinant gene into an arterial wall. 
The transplanted cells may contribute to altering the throm-
bic properties of the vessel lumen by inducing smooth 
muscle cell proliferation and regulating smooth muscle cell 
tone. In addition, genetically altered cells could transmit 
recombinant DNA products. 
Polymer surfaces have been modified by plasma applica-
tion to prepare membranes for dialysis and ultrafiltration. 
Hiroo Iwata et al. in Journal of Membrane Science, vol. 38, 
(1988), pp. 185-189 discloses a macroporous poly 
(vinylidene fluoride) membrane pretreated by air plasma and 
subsequent graft polymerization of hydrophilic monomers 
on the treated surface. Such membranes are said to be 
environment-sensitive and can be used to mimic biological 
membranes or in a closed-loop drug delivery system. J. 
Wolff, Journal of Membrane Science, vol. 36, (1988). pp. 
207-214; F. Vigo et al., Journal of Membrane Science, vol. 
36, (1988), pp. 187-199; F. F. Stengaard, Journal of Mem-
brane Science, vol. 36, (1988), pp. 257-275; and Fang Yuee 
et al .. Journal of Membrane Science, vol. 39, (1988), pp. 1-9 
disclose the preparation of a variety of dialysis and ultrafil-
tration membranes. 
Various polymers have been modified by plasma pro-
cesses to alter surface chemistry, adhesion properties, and 
the like. See H. K. Yasuda et al., Polymer Surfaces and 
Inteifaces, chapter 8, J Wiley & Sons, (1987), pages 
149-162. 
SUMMARY OF THE INVENTION 
4 
pores interconnected between adjacent regions. The distrib-
uted pore chemistry can be obtained, for example, by 
exposing an exterior surface of the porous polymer substrate 
to an oxidizing or reducing gas, containing an oxidizing or 
5 reducing species such as atomic oxygen, hydroxyl and 
amino radicals, or the like, at conditions and for a time 
effective for the radicals to permeate into the pores, react 
with and hydrophilicize an interstitial surface of the 
substrate, essentially without significant mass loss. 
10 In one aspect, then, the present invention provides a 
porous organic polymer having an exterior surface, an 
interstitial surface and a distributed pore chemistry. The 
interstitial surface inclUdes interconnected pores formed in 
the organic polymer which open to the exterior surface. The 
15 distributed pore chemistry includes adjacent hydrophobic 
and hydrophilic regions, wherein the pores in the adjacent 
regions are interconnected. The hydrophilic region can be 
formed by surface modification with oxidizing or reducing 
species selected from atomic oxygen, hydroxyl, amino and 
20 like radicals, and can thus be essentially free of leachable 
surface modification, such as surfactants which have been 
used in the prior art to obtain hydrophilicity. 
The polymer generally has an effective pore diameter of 
at least about 0.01 microns, preferably at least about 1 
25 micron, and more preferably from about 10 to about 2000 
microns. The porous polymer structure is preferably made 
by sintering particulated polymers which are reactive in the 
presence of plasma radicals. Alternately, the porous polymer 
can be made by one of a variety of techniques well known 
30 in the art, such as film drawing, or one of a variety of 
methods conventional in the art, such as described in 
Kesting, Robert E., Synthetic Polymeric Membranes, John 
Wiley & Sons, New York. pp. 237-309 (1985), which is 
hereby incorporated herein by reference. Such polymers 
35 include, as representative examples, polyethylene, 
polypropylene, ethylene-vinyl acetate copolymer, 
polystyrene, styrene-acrylamide copolymer or the like, 
alone or in combination, and optionally including relatively 
inert materials such as polyvinylidene fluoride, 
40 polytetraftuoroethylene, polyalkylsiloxanes or the like. A 
preferred polymer for preparing the distributed pore chem-
istry solid is a sintered polyolefin, such as sintered low 
density polyethylene, high density polyethylene, 
The present invention is directed to the discovery that 
certain porous organic polymers which are reactive with 
plasma radicals have a rate of mass loss which is substan-
tially less than the rate of pore surface modification such that 
the porous polymers can be effectively treated and made 45 
hydrophilic by exposure to atomic oxygen. Exposure of 
organic-coated inorganic materials (say, silica) to atomic 
oxygen generally were observed to result in complete 
removal of the hydrophobic organic coating to leave bare a 
"clean" hydrophilic silica surface. In view of the distinct 
reaction fronts between the hydrophobic and hydrophilic 
interstitial surface region in silica particles treated with 
atomic oxygen, it was to be expected that the similar 
treatment of a porous organic polymer (without any inert 
silica in it) would similarly result in the total or severe mass 
loss of the reactive, organic polymer without the ability to 
retain much of the original interstitial surface and porous 
structure. It was, therefore, quite surprising to discover that 
porous polymers such as sintered polyethylene (POREX) or 
porous polyethylene films (CELGARD K-878) could be 
exposed to atomic oxygen and obtain interstitial surface 
modification, from hydrophobic to hydrophilic, without sub-
stantialloss of the original mass of the polymeric matrix. 
polypropylene, and the like. The sintered polymers generally 
have a void volume from about 35 to about 60 percent. 
The distributed pore chemistry polymer is preferably 
obtained by exposing at least a portion of the exterior surface 
of a hydrophobic polymer substrate to an oxidizing or 
reducing gas, containing an oxidizing or reducing species 
50 selected from atomic oxygen, hydroxyl, amino and like 
radicals, at conditions and for a period of time effective to 
hydrophilicize a portion of the interstitial surface to form the 
hydrophilic region. Preferably, the hydrophilic region 
formed by the exposure to the oxidizing or reducing gas 
55 experiences a mass loss of less than about 10 percent of the 
region before said exposure, more preferably less than about 
one percent. If desired, mass loss can be reduced or elimi-
nated while retaining the ability to hydrophilicize a region of 
a reactive porous polymer by precoating the pore surfaces 
60 with a polymeric dihydrocarbylsiloxane which reacts with 
atomic oxygen or other reactive oxidizing gaseous radicals 
to produce a hydrophilic silicon oxide which protects the 
underlying reactive polymer from further oxidation. 
The present invention is directed to a distributed pore 
chemistry in a porous organic polymer and a method for the 
fabrication thereof. The distributed pore chemistry polymer 
has porous hydrophobic and hydrophilic regions which have 
In a preferred embodiment, the distributed pore chemistry 
65 polymer includes an exterior surface and an interstitial 
surface comprising interconnected pores, formed in the 
polymer which have an effective pore diameter from about 
\' 
• 
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0.1 to about 2000 microns. The distributed pore cheinistry 
polymer also includes hydrophobic and hydrophilic regions 
of the interstitial surface, and pores interconnected across a 
boundary between the hydrophilic and hydrophobic regions. 
Alternatively. the hydrophilic region may comprise the 5 
entire porous polymeric solid. The hydrophilic region is 
created with gaseous oxidizing or reducing species selected 
from atomic oxygen. hydroxyl, amino and like radicals. The 
hydrophilic region is essentially free of leachable surface 
modification, and has a void fraction less than ten percent 10 
greater than a void fraction of the hydrophobic region, more 
preferably less than 0.25 percent greater. 
In another aspect, the present invention provides a method 
for hydrophilicizing a porous, hydrophobic organic polymer 
substrate. The method includes the steps of: (a) exposing an 15 
interior surface of the substrate to an oxidizing or reducing 
gas, containing an oxidizing or reducing species such as, for 
example. atomic oxygen, hydroxyl, amino and like radicals, 
at conditions and for a time effective to hydrophilicize an 
interstitial surface of the substrate essentially without mass 20 
loss; and (b) recovering a substrate having a hydrophilic 
interstitial surface to a depth distal from said exterior 
surface. The mass loss from the interstitial surface exposed 
to the oxidizing or reducing species is preferably less than 10 
percent, more preferably less than 0.25 percent. The expo- 25 
sure is preferably of limited duration to form a distinct 
reaction front behind which the substrate is hydrophilicized, 
and in front of which the substrate remains hydrophobic. 
The recovered substrate desirably has pores interconnected 
across the reaction front. The substrate can be a sintered 30 
poly olefin such as, for example, high density polyethylene, 
low density polyethylene, polypropylene, and the like. The 
polymer substrate preferably has an effective pore diameter 
of at least about 0.1 microns, more preferably at least about 
1 micron and especially from about 10 to about 2000 35 
microns. If desired, the resulting polar groups, including 
alkyl or aryl hydroxyl, ketone, carbolxylic acid, or aldehyde 
groups, formed on the pore surfaces by reaction with atomic 
oxygen or other gaseous oxidizing agents, are used as 
reactive sites for subsequent attachment of a variety of 40 
organic or biological compounds as described more fully 
below. 
6 
of bioactive compounds such as phosphory1cholines, peptide 
sequences, lipids and proteins; pOlymers such as poly 
(ethylene oxide) and poly(vinyl alcohol); and compounds 
comprising acyl terminated long-chain alkyl radicals. The 
dosage over the exposed surface preferably comprises a 
concentration within about 10 percent of an average dosage 
over the surface and is essentially free of atomic oxygen, 
hydroxyl or amino dose variation in a radial direction. As 
one preferred aspect, the method of the invention can be 
used to vascularize a cell mass wherein a prosthesis is 
prepared from a polymeric tube having an outside surface 
biocompatibilized with an adhered layer of cells as 
described above and then inserting the prosthesis into the 
cell mass. In general, an implantable article can be prepared 
by appropriately treating membranes, tubes or molded 
forms. 
Another method of the invention can be used to conduct 
an enzyme-linked immunosorbent assay test A membrane 
having a hydrophilic surface and a hydrophobic surface is 
prepared as described above. Known antibodies are adhered 
to the hydrophobic surface. Then the hydrophilic surface is 
placed in contact with an adjacent absorbent material. The 
antibodies are covered with a test solution, wherein antigens 
specific to the antibodies adhere thereto to form an antibody-
antigen complex and the non-compatible antigens are 
absorbed by the absorbent material. The hydrophobic sur-
face is covered with a solution of the antibodies conjugated 
to an indicating enzyme, wherein the conjugated antIbodies 
and the antigen-antibody complex form an antibody-
antigen-antibody/enzyme complex and excess fluid is 
absorbed by the absorbent material. The antibody-antigen-
antibody/enzyme complex is developed with a solution of 
developing compound reactive with the enzyme to indicate 
presence of the antibody-antigen-antibody/enzyme complex 
as a positive result or an absence of the complexes as a 
negative result. wherein excess developing solution is 
absorbed by the absorbent material. 
Further, a method of the invention can be used to culture 
cells for malignant cell evaluation. A membrane is prepared 
having a surface comprising a plurality of hydrophilic 
regions bounded by hydrophobic regions as described 
above. A group of cells are distributed on the membrane in 
a growth medium, wherein the cells adhere to the hydro-
philic regions at a maximum density of one cell per each 
hydrophilic region and hydrophobic regions are substan-
tially free of adhered cells. The cells are grown on the 
membrane and a count of malignant cells growing on the 
membrane cells is obtained. 
Yet another method of the invention can be used to culture 
cells with enhanced recovery of biological products. A 
Another method of the present invention is based on the 
discovery of an atomic oxygen, hydroxyl radical and/or 
amino radical treatment method capable of producing a 45 
substantially uniform concentration of reactive species. 
Polymer substrates so treated have a uniform distribution of 
hydrophilic functionality on the treated surface. Such func-
tionality is useful for biocompatibilizing polymer articles for 
biomedical and biotechnical applications. 50 membrane with first and second opposing surfaces is pre-
pared wherein the first surface comprises a hydrophilic area 
bounded by a hydrophobic area as described above. Cell 
culturing and product compartments are formed separated 
In a broader sense, the present invention provides a 
biotechnical method, comprising the steps of: (a) exposing 
a hydrophobic exterior polymer surface to a substantially 
axially uniform dosage of atomic oxygen, hydroxyl or 
amino radicals at a temperature below about 100° C. sufli- 55 
cient to form a uniform layer of hydrophilic hydroxyl or 
other polar organic functional groups on said surface, 
wherein the dosage is generated by a flowing afterglow 
microwave discharge, wherein the surface is outside of a 
plasma produced by the discharge; and (b) recovering a 60 
biocompatible article. The method may further comprise the 
steps of grafting a compatibilizing compound to the surface 
following the exposing step and adhering a layer of living 
cells to the compatibilizing compound. The grafting step 
may include the preliminary step of treating the surface with 65 
a dihalodialkylsilane coupling agent. The compatibilizing 
compound is preferably selected from the group consisting 
by the membrane, wherein the first membrane surface is 
adjacent the cell culturing compartment and the second 
membrane surface is adjacent the product compartment, the 
cell culturing compartment comprising cells in a growth 
medium, the cells having a gene for the expression of a 
desired product. The cells are induced to adhere to the 
hydrophilic area of the first surface of the membrane, 
wherein the cells polarize with a basal cell wall adjacent the 
first surface. Nutrient migration is induced from the nutrient 
compartment to the cells compartment by maintaining nutri-
ent in the cell culturing compartment, wherein the cells 
absorb the nutrient and in response thereto secrete a product 
preferentially through the basal cell wall and the membrane 
into the product compartment. 
5,935,845 
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Yet a further method of the invention can be used to 
culture cells with self-replenishing nutrients. A membrane is 
prepared with a first hydrophobic surface and a second 
hydrophilic surface as described above. A nutrient compart-
ment and a cells compartment are formed on opposite sides 5 
of the membrane, wherein the second surface is adjacent the 
nutrient compartment and the first surface is adjacent the 
cells compartment, the nutrient compartment comprising a 
solution of nutrient and the cells compartment comprising 
cells in a growth medium. Migration is induced of said 10 
nutrient from said nutrient compartment to said cells com-
partment by maintaining a concentration of said nutrient in 
said nutrient compartment. 
In another embodiment, the invention provides biotech-
nical polymer articles suitable for use in biomedical or 15 
biotechnical applications, comprising at least one surface 
biocompatibilized at least in part by the method described 
above. The biocompatibilized surface can comprise a sub-
stantially uniform distribution of reactive hydrophilic 
functionality, a compatibilizing compound grafted to the 20 
surface using the hydrophilic functionality and/or a layer of 
living cells adhered to the surface using the hydrophilic 
functionality and/or the compatibilizing compounds. 
Examples of such articles include vascular prostheses, 
membranes, dressing textiles, molded implants having sur- 25 
faces inhibiting platelet adhesion and articles having sur-
faces enhancing cell adhesion. 
In a further embodiment, the invention provides a biore-
actor comprising a housing; a membrane having at least a 
portion of one biocompatibilized surface made by the 30 
method described above dividing the housing into an oppos-
ing nutrient compartment and product compartment; and 
cells in a growth medium in the nutrient compartment. 
In another embodiment, a cell or tissue culture flask 
comprises a housing and a porous polymer structure 35 
mounted in the housing. Cells to be cultured are adherent to 
a hydrophilic, interstitial surface in the porous polymer 
structure. A growth medium is in fluid communication with 
pores interconnected between an exterior surface of the 
polymer structure and the interstitial surface. The intercon- 40 
nected pores preferably have an effective diameter at least 
about 5 times the average diameter of the cells as attached 
to the interstitial surface. The hydrophilic surface in the 
polymer structure is preferably obtained by exposing an 
exterior surface of a porous, hydrophobic organic polymer 45 
substrate to an oxidizing or reducing gas from a flowing 
afterglow discharge device, containing an oxidizing or 
reducing species such as atomic oxygen, hydroxyl, amino 
and like radicals, at conditions and for a time effective to 
hydrophilicize an interstitial surface of the substrate, and 50 
recovering the polymer structure. The substrate preferably 
has a rate of mass loss from the interstitial surface exposed 
to the oxidizing or reducing species substantially less than a 
rate of hydrophilicization. A compatibilizing compound can 
be grafted to the hydrophilic, interstitial surface following 55 
the exposure step. The compatibilizing compound can be 
grafted to the surface using a dihalodialkylsilane coupling 
agent. The compatibilizing compound is, for example, 
selected from phosphorylcholines, peptides, lipids, proteins, 
or the like. Or, the compatibilizing compound can be a 60 
polyvinyl alcohol, polyethyleneoxide, or the like. The sub-
strate used to prepare the porous polymer structure is 
preferably polyethylene, polycarbonate, polystyrene, or the 
like, or a combination thereof. By appropriately treating the 
porous polymer structure, a modified interstitial surface can 65 
be disposed adjacent the cell-adherent surface for selectively 
retaining a protein secreted from the cells. The modified 
8 
protein affinity surface can be coupled to a lightly 
crosslinked gel, for example, dextron, agarose, 
polyacrylamide, or the like, with attached ligands, having an 
affinity for the secreted protein. The gel-filled porous poly-
mer structure can be prepared by the exposure to the 
oxidizing or reducing gas, as mentioned above, to hydro-
philicize the interstitial surface to an initial depth spaced 
from the exterior surface, coupling the gel to the interstitial 
surface, derivatizing the gel with the protein affinity ligand, 
crosslinking the gel, and exposing the exterior surface of the 
substrate to the oxidizing gas to remove the gel to a lesser 
depth than the initial depth of treatment. This forms a 
hydrophilicizedregion from the exterior surface to the lesser 
depth, and an affinity gel-coupled region from the lesser 
depth to the initial depth. The porous polymer structure can 
be a sheet, or more preferably, a plurality of longitudinal, 
spaced-apart ridges secured to an interior surface of the 
housing. The housing can be cylindrical with a rectangular 
transverse cross-section, or in one preferred embodiment, 
the housing has a circular transverse cross section and the 
polymer structure is mounted on a longitudinal interior 
surface of the housing. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a side sectional view of a cell-culturing T-flask 
according to one embodiment of the present invention. 
FIG. 2 is a cross-sectional view of the T-flaskofFIG. 1 as 
seen along the lines 2--2. 
FIG. 3 is a side sectional view of a cell-culturing roller 
flask according to another embodiment of the invention. 
FIG. 4 is a cross-sectional view of the roller flask of FIG. 
3 as seen along the lines 4-4. 
DESCRIPTION OF THE 1NVENITON 
A substantially uniformly compatibilized polymer article 
for a biologic environment, i.e. in the presence of bioactive 
molecules, can be obtained by treating a sufficient amount of 
surface of the article with a substantially uniform concen-
tration of an oxidizing or reducing plasma species, then 
optionally grafting compatibilizing compounds to the 
treated surface. In addition, the grafted substrate may be 
used as a base for succeeding grafts or as an adhesive layer 
for proteins or living cells. 
In one aspect, a hydrophobic polymer substrate may be 
treated with a substantially uniform concentration of atomic 
oxygen, hydroxyl or amino radicals to form a substantially 
uniform hydrophilic surface layer on the substrate. The 
hydrophilic surface substantially comprises reactive 
hydroxyl functionality. A hydrophilic surface may be used to 
enhance water wettability of the substrate, enhance surface 
adsorption of proteins or other bioactive compounds, 
enhance surface adherence of cells or as a base for further 
surface compatibilizing grafting reactions. 
As another aspect, the substantially hydrophobic surface 
layer may be made to undergo one or more modifications in 
a series of chemical reactions to graft a compatibilizing 
compound to the substrate surface. Various kinds of com-
patibilizing compounds are contemplated and may be used 
so long as the result is a substrate more compatible with the 
biologic environment of the application involved. By 
"compatibilizing," it is meant that an otherwise non-biologic 
surface, e. g. hydrophobic polymer surface, is made more 
like known biologic surfaces to a substantial but varying 
degree. 
The compatibilizing compound may be bioactive, i. e. 
found in life processes, or .non-bioactive, but serving to 
• 
\' 
r 
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compatibilize the substrate in situ. Representative examples 
of bioactive compounds which may be used include com-
pounds having phosphoryl-choline functionality, peptides, 
proteins, lipids, nucleic acids, and the like. Substrates with 
protein or other bioactive grafts have several compatibiliz- 5 
ing applications. One important use is preventing thrombo-
sis around an implanted article by mimicking biologic 
surfaces. As another use, grafted proteins may serve as an 
adherent surface or adsorbent for cultured cells. 
10 
As an intermediate step, a silane coupling agent may be 
used to graft the compatibilizing compound to the substrate 
surface. Such silane grafting reactions are known. Generally, 
the coupling agent comprises a suitable functional group 
which may be grafted to the substrate surface. The grafted 
functional group may be made to undergo subsequent 
chemical reaction with an appropriate compatibilizing com-
pound. Alternatively, the silane coupling agent is attached to 
the compatibilizing compound first. 
One class of suitable silane coupling agents has the 
formula: 
OR' 
I 
R-Si-OR' 
I 
OR' 
Other compounds which have been found to have a 10 
compatibilizing use include polymeric groups such as poly 
(vinyl alcohol) and poly(ethylene oxide); and an acyl ter-
minated upper alkyl radical such as an acyl terminated alkyl 
radical of about 16 carbon atoms. The former have been 
found to inhibit platelet sticking in the blood stream, see Y. 15 
Ikada, "Development of a Polymer Surface with anti-
adherent Platelet Properties" compiled in Polymers in Medi-
cine and Surgery, Plastics and Rubber Institute Science and 
Technology Publishers, Hornchurch, UK, 1986 which is wherein R' independently comprises lower alkyl radicals or 
hereby incorporated herein by reference. The latter has been hydrogen, R comprises R"-Y wherein R" comprises a lower 
found to have enhanced affinity for blood proteins such as 20 alkyl radical and Y is selected from the group consisting of 
albumin. This albumin layer inhibits clotting at the com- terminal amino, mercapto, hydroxy, alkoxy, glycido and 
carboxy functionality. Representative examples include 
patibilized surface. See Tsai, Chi-Chun et al., ASAIO, vols. 3-aminopropyltris-(methoxy)silane, 3-mercaptopropyltris 
XXXIV (1988) and XXXVI (1990) which are hereby incor- (methoxy)silane, 3-glycidopropyltris(methoxy)silane, 
porated herein by reference. 25 2-carboxyethyltris-( ethoxy)silane, 4-hydroxybutyltris 
As a further aspect, a substrate comprising a protein (propyloxy)silane, and the like. Another type silane coupling 
grafted polymer surface can have living cells such as endot- agent comprises dihalodialkylsilanes. Exemplary is 
helial cells adhered to the protein grafts. Furthermore, such dichlorodimethyl-silane. 
cells can be genetically altered to transmit recombinant In addition, a first coupling agent grafted to the substrate 
DNA products. Such substrates can be utilized in vascular, 30 or reacted with the compatIbilizing compound may form an 
skeletal, and the like prostheses; as a vascular network for intermediate for a reaction with one or more additional 
micro gravity cell culturing processes; or in earth-based coupling agents. Exemplary of such additional coupling 
bioprocessing methodology, e. g. affinity columns. Vascular compounds is tresyl chloride: 
prostheses can be used in persons suffering advanced arte-
riosclerosis. 35 o II For the compatibilizing surface treatment, highly reactive 
atomic oxygen or hydroxyl radicals are preferred oxidizing 
agents, and amino radicals are the preferred reducing agents. 
Atomic oxygen has the advantage over molecular oxygen of 
CF3CH2-S-Cl 
II 
o 
obtaining a distinct oxidation front, generally on the order of 40 • • • • • 
a molecular diameter, i. e. from about 50 to about 5000 Tres~l chl?nde reac~s WIth a tenmnal ammo group m a 
tr In ddi>: t' d t . th glycme urnt of a peptide sequence to couple the sequence to ~gs oms. a uon, a OIDlC oxygen oes no reqwr~ e the underlying substrate. 
high temperatures that th~rmal, molecular .oxygen re~wres, The method of the present invention is suitable for use on 
so there are no the~~y mduced changes m the phYSIcal ~r most polymer substrates having inert hydrophobic surfaces. 
structur~ charactenstics of the polymer when the atolDlc 45 Such polymers are either carbon or silicon based. Repre-
oxygen IS used at a low temperature, preferably below about sentative examples of typical carbon-based polymers 
1000 C., and. more preferably below about40° C. include polyolefins such as high and low density polyeth-
To obtain uniform treatment of the substrate, a flowing ylene and polypropylene, poly(ethyleneterephthlate), 
afterglow discharge type atomic oxygen reactor is generally polyimides, polystyrene, polytetrafluoroethylene, poly 
required. The surface of the article to be treated should be 50 (vinylidene fluoride), and the like. Examples of suitable 
out of the plasma and the reactor configured to deliver a silicon-based polymers include polydimethylsiloxane, 
relatively uniform dose of oxygen atoms. The specific polyphenylsiloxane, dimethylsiloxane/methylvinylsiloxane 
design of the flowing afterglow device will depend, of copolymer, crosslinked polysiloxanes obtained by 
course, on the shape of the polymer article using the well hydrosilylation, condensation or free radical crosslinking of 
known principles of diffusion/reaction kinetics in flowing 55 siloxane prepolymers or organosiloxane polymer mixtures, 
systems. and the like. 
To limit oxidation or reduction of the outer portion of the Substrates may have most commonly known forms 
substrate and avoid altering the bulk properties of the including textiles, tubes, films, membranes, sheets, molded 
polymer, highly reactive atomic oxygen, hydroxyl radicals forms, as well as composite films, membranes, textiles, and 
and amino radicals are the preferred oxidizing and reducing 60 the like with other inert polymeric and non-polymeric mate-
agents, produced in accordance with the apparatus and rials used for reinforcement. As an example, a breathable, 
methodology described in U.S. Pat. Nos. 5,141,806 and hydrophobic polysiloxane membrane reinforced with poly 
5,215,790 to Koontz which are hereby incorporated herein (tetrafluoroethylene) is sold under the tradename Sn..ON by 
by reference. Amino radicals are produced by using an Bio-Med Sciences, Inc. These membranes are typically used 
ammonia gas in the reactor in place of the oxygen- 65 as wound dressings, gas and fluid exchange membranes, etc. 
containing gas used to produce atomic oxygen andlor The distributed pore chemistry (DPC) embodiment of the 
hydroxyl radicals. present invention can be obtained by treating a porous 
5,935,845 
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organic polymer with the gaseous radicals from the plasma. 
The polymers suited for treatment in this embodiment are 
generally reactive with the plasma radicals and will expe-
rience mass loss upon exposure to the radicals for a sufficient 
period of time. However, the polymer and treatment condi-
tions are selected in this embodiment so that the rate of mass 
loss is relatively low compared to the rate of surface 
modification with the plasma radicals in the interstitial pores 
of the polymer matrix. In this manner, the polymer matrix is 
relatively unchanged by the treatment, and the supporting 
structure generally retains its bulk and mechanical proper-
ties. However, the surface of the pores exposed to the 
radicals diffusing through the pores reacts with the radicals 
to become modified by the formation of polar groups as the 
reaction product between the diffusing radicals and the 
exposed surface. 
As the radicals diffuse through the pores of a hydrophobic 
polymer, the surfaces of the pores become modified with 
polar groups and are made hydrophilic. Generally, the 
diffusion of the radicals from an exterior surface of the 
polymer proceeds in a distinct front. Behind the front, the 
interstitial surfaces of the pores become hydrophilic from 
the addition of polar groups. Ahead of the front, the pore 
surfaces remain hydrophobic. However, if the reaction front 
is allowed to pass through the entirety of the polymer 
material, the bulk material is rendered hydrophilic. The 
distribution of the pore chemistry between hydrophilic and 
hydrophobic regions is generally detennined by controlling 
the exposure to the reactive radicals and the shape, direction 
and distance of the reaction front through the pores. 
To further inhibit mass loss, the pore surfaces can be 
precoated with an organosiloxane, preferably a dihydrocar-
bylsiloxane such as polydialkylsiloxane or polydiarylsilox-
ane. Polydimethylsiloxane sold under the trade designation 
DOW CORNING 704 is a representative example. The 
siloxane is non-volatile and can be applied in a solvent 
vehicle, such as hexane, to the porous polymer substrate. 
The solvent is evaporated, for example in a vaccuum oven, 
to leave the pore surfaces coated with the hydrophobic 
siloxane. When the substrate is exposed to the oxidizing 
species, the hydrophobic siloxane reacts to form a hydro-
philic silicon oxide coating. The coating is generally inert 
and serves to protect the underlying reactive polymer from 
further oxidation by the oxidizing species diffusing the past 
oxidized surface. In this manner, the rate of mass loss is 
significantly reduced while at the same time allowing hydro-
philicization of the pore surface. 
Organic polymer substrates which can be treated accord-
ing to the present invention to obtain distributed pore 
chemistry solids are generally porous hydrophobic materials 
which are reactive with plasma radicals. The polymer matrix 
structure is preferably permeable, i.e. the pores are inter-
connected to allow fluid flow from an exterior surface into 
an adjacent region in the structure, and from one adjacent 
region to another. 
The polymer substrate is characterized by interconnected 
pores on a larger-than-molecular scale, i.e. the pores gener-
ally have effective diameters larger than about 0.01 microns 
12 
as, for example. polyamide, polyvinylchloride, polyolefin, 
polystyrene, polyurethane. polyacrylate, phenolic, alkyd, 
polyester, cellulose, starch. polysaccharide. polypeptide, 
rubber, gutta percha, and the like. Polystyrene and polyole-
5 fins such as low density polyethylene, high density 
polyethylene, polypropylene and the like are preferred poly-
mer substrates, especially those manufactured by sintering 
finely divided polymer particles at an elevated pressure 
and/or temperature. Sintered polyolefins are available 
10 commercially, for example, under the trade designation 
POREX. 
The DPC hydrophilic/hydrophobic porous polymer can 
be made by exposing an exterior surface of the porous 
polymer substrate to a source of atomic oxygen, hydroxyl. 
15 amino or similar radicals in a particle plasma in much the 
same manner as the treatment of solid polymer surfaces as 
described above. Atomic oxygen reactors such as plasma 
ashers are conventional, for example, but other suitable 
sources of atomic oxygen include ram flux in low earth orbit, 
20 laser photo dissociation, and the like. Oxidation of the 
interstitial surfaces of the porous polymer structure with 
highly reactive atomic oxygen has the advantage of obtain-
ing a distinct oxidation reaction front, generally on the order 
of one effective pore diameter of the structure, a result not 
25 possible with less reactive molecular oxygen which does not 
obtain a sharp reaction front and tends to complete mass loss 
of combustible organic polymers rather than surface modi-
fication. In addition, atomic oxygen does not require the 
high temperatures that thermal, molecular oxygen requires. 
30 so there are no thermally induced changes in the physical or 
structural characteristics of the porous polymer when atomic 
oxygen is used at a low temperature, preferably below about 
100° c., and more preferably below about 40° C. 
The sidearm and drop tower oxygen reactors and general 
35 methodology disclosed in U.S. Pat. Nos. 5,141,806 and 
5,215.790 are particularly preferred for preparing the DPC 
hydrophilic/hydrophobic porous polymers of the present 
invention. U.S. Pat. Nos. 5,141,806 and 5,215,790 are 
hereby incorporated herein in their entirety by reference. 
40 Particulated porous polymer substrates are treated in the 
drop tower. The sidearm reactor is used when uniform 
treatment of relatively larger solid forms of the porous 
polymer substrate is desired, e.g. the treatment of a sheet or 
block to a uniform depth across one exterior surface. 
45 Porous and non-porous compatibilized articles made by 
the method of the invention find widespread use in biotech-
nical and biomedical application. By "biotechnical" it is 
understood to mean application to vitro processes. Examples 
of in vitro processes include manufacturing and purifying 
50 biocompounds such as lipids, complex carbohydrates, pro-
teins and nucleic acids; preparing pharmaceutical chemicals 
used as drugs, drug intermediates, and the like; and cell 
culturing processes for drug manufacture, preparing organ-
isms having altered genes, prostheses manufacture, and the 
55 like. "Biomedical" generally refers to vivo process 
application, i. e. extended contact with ongoing life pro-
cesses. 
(1 angstrom), preferably at least about 1 micron, and espe-
cially from about 10 to about 2000 microns. Thus, the 
present material can be distinguished from semipermeable 60 
solid-phase membranes which generally have interatomic or 
intermolecular openings on a subatomic scale for molecular 
diffusion. The porous substrate can have any desired physi-
The extent of compatibilization depends on the given 
application. Close compatibilization may duplicate the cell 
linings at the location of transplant. Lesser compatibilization 
may only require water wettability of a hydrophilic surface. 
Intermediate compatibilization may mimic a biologic sub-
strate to a greater or lesser extent, enhance adsoxption of 
biologic compounds such as albumin previously mentioned cal shape such as a cube, block, sphere, tube, rod, sheet, or 
the like. 
The polymer in the DPC embodiment can be a synthetic, 
semisynthetic, or naturally occurring organic polymer, such 
65 or prevent adhesion such as that of platelets to reduce 
unwanted clotting also previously mentioned. It is under-
stood that a compatibilized substrate for an in vivo appli-
'I 
• 
• 
5,935,845 
13 
cation is less likely to cause localized damage and/or irri-
tation in an organism. An implant having compatibilized 
surfaces can last longer and is generally less likely to be 
rejected by the organism. A compatibilized substrate for an 
in vitro process will enhance the application and/or yield of 
the biotechnical process. 
Representative examples of biomedical applications 
include contact lenses, dressings for enhancing the healing 
of skin, membranes for blood dialysis, prostheses for the 
vascular and skeletal system, artificial organs, implants for 
reconstructive and cosmetic surgery, implants for fighting 
disease, implants for regulating biological systems, implants 
for providing structural support for directing vascularization 
wherein the support frame implant is later removed, and the 
like. 
Examples of biotechnical applications include gas and 
liquid separation membranes in the manufacture and/or 
purification of pharmaceutical compounds, chromatographic 
resins, improved cell culturing membranes and petri dishes, 
membranes for enhancing an evaluation rate of malignant 
cell growth, vascular conduits for microgravity cell 
culturing, diagnostic membranes for immune response 
testing, and the like. 
Serological techniques such as enzyme-linked immun-
osorbent assay (EllSA) for determining the presence of 
antigens are enhanced by using a membrane wherein one 
surface is made hydrophilic by the method of the present 
invention. Successive sera liquids used by the ELISA test 
can be easily drawn through the membrane into an absorbent 
cotton or tissue paper using surface energy forces, thus 
avoiding undesirable washing steps which would otherwise 
be necessary. In such a manner, waste liquids can be more 
easily limited and confined. The hydrophobic side of the 
membrane is preferably used for the test reagent side and the 
hydrophilic side is set adjacent the absorbent paper to draw 
away the reagents and other test fluids from the test site. The 
EUSA test can be conducted using the modified membrane 
in either the "sandwich" method or the indirect method. The 
methods of the ELISA test are well known in the art. 
Cell culturing techniques can be enhanced using poly-
meric membranes modified by the method of the present 
invention, especially for culturing cells that require anchor-
age to a hydrophilic surface to grow. Modified semiperme-
able membranes having various hydrophilidhydrophobic 
surface patterns can be made by masking the membrane 
before exposure to the atomic oxygen. Such modified mem-
branes can be used as partitions in cell cultures. As one 
example, the membranes may be masked using a checker-
board stencil, and then modified by atomic oxygen treatment 
to form hydrophilic surface areas separated by hydrophobic 
boundaries. In a cell culture, each hydrophilic area com-
prises a separate microculture because cell growth is sub-
stantially confined to the hydrophilic area. Therefore, the 
hydrophilic "squares" typically have an area several times 
larger than the size of the cell to be grown. Cells cultured on 
the checkerboard membrane at an average density of about 
one cell per hydrophilic square or less form microcultures 
which can be used to greatly reduce the time and amount of 
materials required, for example, to make malignant cell 
growth evaluations of cells taken from tissue biopsies. A 
percentage of malignant growing cells can then be easily 
determined by observation of the whole. 
Typically, tissue biopsy cells are evaluated for cancerous 
growth by culturing individual cells separately, and then 
observing the growth after a period of time. To insure no 
more than one cell per culture, the cells are ordinarily diluted 
serially using growth media to a concentration of· about 
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0.6-0.8 cells per culture area. The less culture area required 
to differentiate between the cells, the less time and nutrients 
that are generally necessary for the evaluation. Typically, the 
area of the prior art evaluation cultures is about 0.25 cm2• 
Cells can be cultured in a vessel partitioned by a semi-
permeable membrane into compartments. Nutrients and/or 
products made by the culture may diffuse across the mem-
brane. For example, a cell culture can be grown in a growth 
medium in a vessel wherein nutrients are self-replenished as 
used. The vessel is partitioned by a modified membrane of 
the present invention into dual compartments. The modified 
membrane has a hydrophobic surface and a hydrophilic 
surface. In one compartment adjacent the membrane hydro-
phobic surface, cells are cultured. The other compartment 
adjacent the membrane hydrophilic surface has growth 
medium. Nutrient diffusion from the nutrient compartment 
replenishes nutrients in the cells compartment as they are 
used. 
Bioreactors partitioned by the modified membranes of the 
present invention as above can polarize the cells and thereby 
enhance production and separation of secreted biological 
products. Depending on the cells involved, polarization can 
occur in due course as cells adhere to a hydrophilic surface 
on the membrane and/or in response to a concentration 
gradient set up by a nutrient factor diffusing across the 
membrane. In either case, the cells define a basal cell wall 
adhered against the membrane partition and an opposite 
apical cell wall. The membrane of such bioreactors prefer-
ably has a hydrophobic surface adjacent a cell culture 
compartment except for an isolated hydrophilic area, such 
as, for example, a line or a strip for cell attachment The 
other surface of the membrane adjacent a nutrient compart-
ment can be hydrophobic or hydrophilic. Nutrients from the 
nutrient compartment diffuse through the membrane by 
concentration gradient to replenish nutrients used by the 
cells. Desired products made by the cells secrete through the 
basal cell wall and diffuse through the membrane partition 
into the nutrient compartment In such manner, desired cell 
products can be recovered without lysing the cells. 
The cell or tissue culture flask of the invention is illus-
trated in several illustrative embodiments in FIGS. 1-4 
wherein like parts are referred to by like numerals. The 
T-flask 10 in FIG. 1 has a generally longitudinal housing 12 
with a generally rectangular or other suitable transverse 
cross-section. A first end 14 is sealed and a second end 16 
is provided with a conventional port 18 for gas exchange and 
media changeout. The growth media is typically less than 
about 1.5 mm (V16-in.) deep above a flat porous polymer 
insert 20 which is generally about 1-5 mm thick, typically 
about 1.6 mm (VIii-in.) thick. The housing 12 and ends 14, 
16 are conventionally polystyrene or polycarbonate, but any 
suitable materials may be employed. The housing 12 is 
typically cut to the desired length and the ends 14, 16 and 
insert 20 are glued or welded (e.g. ultrasonically) in place to 
fabricate the T-flask. 
The insert 20 is generally rectangular corresponding to the 
dimensions of the flask 10. The insert 20 has porosity which 
depends on the size of the cells or tissue to be cultured. 
Generally, the effective pore diameter should exceed the 
diameter of the cells as attached to the interstitial surface, 
and preferably the pore diameter is about five times the cell 
diameter, to allow media diffusion through the intercon-
nected pores and around the attached cells. The use of the 
interstitial surface as an attachment surface for the cells 
greatly increases the surface area for cell attachment and 
growth, and thus greatly increases the density of the cells 
being cultured in a given flask volume or surface area. 
5,935,845 
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The pore surface chemistry can be modified as desired to 
enhance cellular attachment, protein adhesion, etc. as 
described above. The insert 20 can be treated, for example, 
by exposure to atomic oxygen or amino radicals to render 
the interstitial surface hydrophilic to enhance cellular adhe- s 
sion. If desired, proteins are coupled to the hydrophilic 
interstitial surface to further enhance cellular adhesion, 
substantially as described herein. Also, the pore surfaces can 
16 
surfaces thereof continuously receive nutrients and oxygen. 
Again, as in the embodiment of FIGS. 1-2, the roller bottle 
of FIGS. 3-4 has markedly increased cell adhesion/growth 
surfaces as compared to conventional roller bottle designs 
wherein only a flat interior surface on the inside wall of the 
flask is available. 
The invention is illustrated by the following examples. 
EXAMPlE 1 
A polytetrafluoroethylene reinforced silicone membrane 
sold under the tradenarne Sn..ON by Bio-Med Sciences, Inc. 
be modified by coupling with a peptide ligand for selectively 
binding proteins expressed by the cells as a product, to 10 
facilitate recovery of the protein product directly from the 
insert 20. In this manner, the media and the cells can be 
washed from the insert 20, and the protein product can be 
efficiently cleaved from the pore surfaces without the need 
for purifying the protein from the growth media. 1S of Bethlehem, PA is uniformly treated with atomic oxygen 
in an atomic oxygen reactor having a specimen holding 
sidearm. Operating conditions are shown in Table 1 The 
membrane initially has a hydrophobic surface which after 
treatment acquires hydrophilic hydroxyl functionality as 
follows: 
The pore surfaces in the insert 20 can also have the 
distributed pore chemistry (DPC) as described above. In this 
embodiment, the insert 20 is modified to a depth from an 
upper exterior surface for cell attachment and growth. Below 
the cell growth modification layer, e.g. to a lower exterior 
TABLE 
before after 
CH3 CH3 I OH OH I I I I 
-t-Si-O-Si+':-
-t-Si-O-Si+':-I I 0 +180 I I 0 +6HzO +4COz 
CH3 CH3 I OH OR 
Sub-
Surface 
surface, the pore surfaces are modified for selective retention 
pressure (Fa) 
temp (" K.) 
gas mixture 
C(z)(AO/cm') 
'Xl 
298 
10% O2 inAr 
4 x 10'4 
EXAMPlE 2 
of a protein product secreted by the cells, for example, by 
filling the pores with a lightly crosslinked affinity gel or a 
lightly crosslinked dextron, agarose or polyacrylamide gel 
having attached affinity ligands. The DPC modification is 
obtained, for example, by atomic oxygen/amino radical 
exposure of the insert 20 to an initial depth (or through the 
complete depth), coupling of the gel material to the hydro-
philic pore surfaces, removal of the gel materials to a lesser so 
depth by atomic oxygen exposure and derivitizing the result-
ing hydrophilic gel-free pore surface with any cell adhesion 
promoters. Crosslinking and affinity ligand coupling of the 
The membrane of Example 1 is reacted with a silane 
45 
coupling agent to graft glycidyl functionality to the substrate 
gel can be effected as intermediate steps in an appropriate 
sequence or order. 
In a roller bottle embodiment as best seen in FIGS. 3-4, 
55 
a flask 30 is constructed of a housing 32 and respective first 
and second ends 34 and 3(j as in the T-flask embodiment of 
FIGS. 1-2. However, the housing 32 is circular in cross-
section (see FIG. 4) and is provided with a plurality of 60 
porous polymer inserts 38, each of which is modified as 
described in connection with the insert 20 above. 
Each of the inserts 38 is ultrasonically welded or press fit 
into a respective slot (not shown) on an inside diameter of 
the housing 32. In use, the roller bottle flask 30 is continu- 65 
ously turned along its axis to alternately immerse and expose 
each insert 38 so that the cells culturing on the interstitial 
surface. The grafting reaction proceeds as follows: 
~ 
-Si-OH + ~ -Si-O-Si-R 
I 
o 
I 
-Si-OH 
I ~, 
o R' I 0 
-Si-O-Si-R 
+ RSi(OR'h, 
to to ~, 
wherein R and R' are as previously defined. 
3-Glycidylpropyltrismethoxysilane obtainable from Huls-
Petrarch (item 06772) is dissolved in an ethanol/water 
solution (95 wt % ethanol) to make a 1 wt % solution of the 
glycidyl compound. The pH of the solution is adjusted to 
between about 4.5-5.5 with sodium acetate. The membrane 
from Example 1 is placed into the solution for 1-2 minutes 
then removed and rinsed with ethanol. After drying for 5-10 
min at 110° C. or for 2.5 hrs in a desiccator, the membrane 
is used for further reaction. 
'/ 
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EXAMPLES 3-4 
Compatibilizing phosphorylcholine functionality is 
grafted to the surlace of the membranes of Example 2 to 
mimic a cell membrane. 
The membrane of Example 2 is stirred in a 40° C. water 
solution of ethyleneglycophosphorylcholine for 16 hours. 
The pH of the reaction medium is 4.5 to 6. The reaction is 
as follows: 
o 
+ ~ /\ 
-Si-0-Si-(CHih-0 -CH-CH2 
I ~ 0 + I ~ /\ 
-Si-0-Si-(CH2h-0 -CH-CH2 to ~, 
o 
II 
HO-CH2CH20POCH2CH2N(CH2h -I + 
0-
I R' OH 0 
l' 0 I II 
-Si-OSi(CH2h O -CHCH20 -CH2CH20POCH2CH2N(CH2h 
I ~, , + 0-
o OH 0 I ~ I II 
-Si-OSi(CHzhO -CHCH20- CH2CH20POCH2CH2N(CH2h to ~, I + 
0-
As an alternative example, the membrane of Example 1 is 
coupled to the ethyleneglycophosphorylcholine using 
dichlorodimethylsilane. First, the phosphorylcholine is 
reacted at with the dichlorodimethylsilane in anhydrous 
tetrahydrofuran (fHF) using excess silane for 1 hr at 25° C. 
to prepare a chlorosilanelphosphorylcholine intermediate. 
Next, the intermediate product is recovered by evaporating 
the solvent and excess unreacted silane. The intermediate is 
then reacted with the Example 1 membrane in dry THF also 
at 25° C. for 16 hrs with stirring to complete the graft 
reaction. 
EXAMPLE 5 
18 
I R' OH 
l' 0 I 
5 
-Si-OSi(CH2hO - CHCH20 I ~ 
o OH I R' o I 
- Si-OSi(CH2hO - CHCH20 
to ~ 
I R' Tresyl 
l' 0 I 
10 
-Si-OSi(CH2hO - CHCH2Tresyi 
I ~ 
o +GRGD-
I R' Tresyl o I 15 
-Si-OSi(CH2hO-CHCH2Tresyl 
to ~ 
20 
I R' NH(GRGD) 
l' 0 I 
- Si-OSi(CH2hO - CHCH2NH(GRGD) I ~, 
o 
I R' NH(GRGD) o I 
25 
-Si-OSi(CH2hO -CHCH2NH(GRGD) 
to ~. 
The glycidyl functionalized membrane from Example 2 is 
30 initially hydrolyzed in dilute acid (PH of about 2) by stirring 
for 2 hrs at 25° C. The hydrolyzed glycidyl groups are 
reacted with tresyl chloride in dry ether. The membrane is 
contacted with a 1.0 wt % ether solution of the tresyl 
chloride at 25° C. for 15 min then rinsed with 0.2 M 
35 bicarbonate buffer solution having a pH of 10. In fresh buffer 
solution, the tresyl chloride functionalized membrane is 
reacted with the peptide for 20 hrs at 250° C. The peptide 
sequence is attached at the terminal amino functionality on 
40 the glycine unit. 
EXAMPLE 7 
In the following example, a vascular prosthesis is initially 
made according to Example 6 except that the SILON 
45 substrate has the form of a small bore tube. In the atomic 
oxygen treating first step, the outside surface of the tube is 
made hydrophilic to ~ of the wall thickness. Arterial endot-
helial cells are cultured on the treated surface to form a In this reaction, a compatibilizing polymer segment is 
grafted to the surlace glycidyl functionality of the membrane 50 
of Example 2. 
closely compatibilized article which is suitable for implant 
into a patient suffering advanced arteriosclerosis. 
A poly(vinyl alcohol) segment is grafted to the membrane 
by reaction in water at 25° C. for 16 hrs with stirring. 
Reaction pH is 4.5-5.5. Further details regarding the opti-
mized surface loading (# of grafts) and molecular weight 55 
distribution of the polymer with respect to a particular 
application may be found in the article by Y. Ikada men-
tioned previously. 
60 
EXAMPLE 8 
A vascular prosthesis is made according to Example 7 
except that the tubular silicone substrate has a microporous 
form made by a replamineform casting procedure described 
in Stimpson above which is hereby incorporated herein by 
reference. 
EXAMPLE 9 
EXAMPLE 6 
A tetrapeptide glycine-arginine-glycine-asparagine 
(GRGD) containing the cell adhesion sequence arginine-
glycine-asparagine (ROD) is grafted to the surface of the 
membrane of Example 2. Tresyl chloride is used as a second 
coupling agent as follows: 
In the following example, an ELISA serological immune 
diagnostic technique is conducted using a 2.5 em diameter, 
100 mm thick SILON membrane treated with a uniform 
65 dose of atomic oxygen according to the procedure of 
Example 1 so that one side is hydrophilic and the other 
remains hydrophobic. The direct sandwich method is used. 
5,935,845 
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The membrane is placed hydrophilic side down on a glass growth differentiation factors wherein the cells are polarized 
petri dish and a drop of antiserum containing a polyclonal by a 2.5 cm2 Sn..ON diffusion membrane which is 100 nun 
anti-lgG antibody obtained as a 1 ml concentration from thick The membrane is treated on both sides with a uniform 
Sigma Corp. of St. Louis is placed on the membrane and dose of atomic oxygen according to the procedure of 
allowed to dry. Next, absorbent tissue paper is placed under 5 Example 1. One membrane side is hydrophilic and the other 
the membrane hydrophilic side and a drop of a test serum remains hydrophobic except for a horizontal hydrophilic line 
containing complementary antigens is placed over the anti- made by masking the treated surface. In the culture, the cells 
bodies. The complementary antigens adhere to the anti-lgG are added to the partition side having the linear hydrophilic 
antibodies and excess fluid is absorbed through the mem- 10 area bounded by the hydrophobic area and growth media is 
brane into the tissue paper. Using fresh absorbent tissue added to the other side of the membrane having the hydro-
paper in a fresh petri dish, a second drop of antiserum philic surface. The cells polarize as a matter of course upon 
containing 1 part complementary anti-lgG antibodies per adherence to the hydrophilic "line" so that a distinct basal 
2000 parts water is placed over the antibody-antigen com- cell wall is formed adhered to the membrane as well as an 
bination except that these second antibodies are conjugated 15 opposite apical cell wall. In the course of the CUlture, 
to an enzyme alkaline phosphatase. Adherence of these nutrients diffuse across the membrane to replenish the cell 
additional antibodies to the antigens mark the antigens with growth media and the cell growth differentiation factors 
the enzyme. Excess liquids diffuse through the membrane produced by the cultured cells are secreted by the basal cell 
and are absorbed by the paper. Using fresh tissue paper in a 20 wall and migrate through the membrane partition. After 30 
fresh petri dish. a drop of phosphatase-reactive chromagen days, the confluency in the opposite compartment is greater 
is placed over the membrane "sandwich." Since phosphatase than 10 picomoles of the growth differentiation factors. 
marked antigens are present, a black chromagen-
phosphatase product forms. Excess fluid is drawn through 
the membrane and is absorbed leaving the black colored 25 
"sandwich." The modified membrane allows waste liquids 
to be absorbed away from the test area for easy disposal. 
EXAMPLE 12 
In the following example, a modified membrane can be 
used to allow continual replenishment of nutrients to a cell 
culture. A petri dish culture is partitioned by modified 
membrane as described in Example 11 except that the 
EXAMPLE 10 
In the following example, time required to differentiate 
the growth rate of normal cells from malignant cells in a 
tissue biopsy is determined using a hydrophilic modified 
membrane of the present invention. The membrane has a 
surface wherein a plurality of hydrophilic surface areas are 
separated by a hydrophobic boundary so that each hydro-
philic area is an isolated microculture. 
30 Sn..ON membrane is treated with atomic oxygen so that one 
side is hydrophilic and the other remains hydrophobic. The 
hydrophilic side forms the nutrient compartment and the 
cells are cultured in growth media adjacent the hydrophobic 
side. As nutrients in the growth medium are used by the 
35 cells, replenishing nutrients diffuse from the nutrient com-
partment to the cells compartment through the membrane. 
The test is undertaken using a 2.5 cm diameter, 100 mm 
thick Sn..ON membrane exposed to a uniform dosage of 40 
atomic oxygen according to Example 1, except that the 
membrane is masked during the atomic oxygen treatment. 
The mask gives the membrane a surface feature wherein 
hydrophilic areas of about 200 nun2 are bounded by simi-
45 larly sized hydrophobic regions in a checkerboard manner. 
The treated membrane is placed in a petri dish. The biopsy 
cells are serially diluted with cell culture media so that there 
will be about 0.7 cells per 200 nun2 membrane area in the 
culture and the growth solution containing the cells is then 50 
added to the dish. 
After one week, observation of the growth area under a 
microscope indicates that malignancy growth evaluation 
may be made in one tenth the time ordinarily required using 55 
0.25 cm2 size cultures in the prior art methods. Likewise, 
only one tenth the amount of culture materials is required. 
EXAMPLE 11 
EXAMPLE 13 
Discs of porous and nonporous high density poylethylene 
(HDPE) were treated with atomic oxygen to evaluate mass 
loss and the development of hydrophilicity. The porous 
polyethylene discs were cut from 1.6 mm (Vl6-in.) thick 
specimens obtained from Porex Technologies and had 
coarse, medium and fine pores with respective nominal pore 
diameters of about 250 J.Ull, 49-90 J.Ul1 and 10-20 J.Ul1. The 
nonporous HDPE was obtained in the form of a 0.025 mm 
(1 mil) film. The discs had a diameter of about 19 mm (0.75 
in.) and were cleaned by rinsing in a mixture of 1,1.1-
trichloroethylene and ethanol and drying in a vacuum over-
night. 
Duplicate sets of the discs were placed in the sidearm 
reactor of Example 1 and exposed to an atomic oxygen 
concentration of 5x10141cm3. The weight of each disc was 
recorded at periodic intervals over a total exposure time of 
In the following example, a modified membrane of the 
12-15 hours to monitor mass loss. The results are presented 
in Table 2. In addition, scanning electron micrographs 
(SEM) of discs exposed to 3.6x1014/cm3 atomic oxygen 
60 atoms in the sidearm reactor for 166.25 hours were taken for 
present invention is used to separate a cultured product comparison to unexposed material. As seen from the data in 
comprising cell growth differentiation factors from the cells Table 2, the rate of mass loss varied according to material 
without lYSis. pore size, i.e. the larger the pore diameter, the greater the 
Normal human primary cells taken from a surgical section 65 mass loss rate. Apparently, the mass loss rate depends mostly 
are cultured in a petri dish having a modified membrane on the amount of surface area available for reaction, and not 
partition. CO2 incubation conditions are used to produce cell on diffusion. Estimates of the effective surface area of the 
\I 
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discs calculated from the loss rate relative to the nonpoc()l1s 
HDPE were corroborated from surface· area estimates by 
SEM. The SEM also showed rounding of particles in the 
coarse pores and visible pitting in the medium and fine 
pores, with changes occurring uniformly across the thick- 5 
ness of the discs. 
Discs were similarly exposed to 5x1014!cm3 atomic oxy-
gen atoms in the sidearm reactor for periods of time ranging 
from three seconds to ten minutes to characterize develop-
10 
ment of hydrophilicity as reflected in the amount of water 
uptake of the exposed samples. An amount of water suffi-
cient to wet the hydrophilic portion was dropped onto the 
surface of each disc, and any excess was removed by pipet. 
The increase in mass due to water uptake was recorded. and 15 
the results based on an average of three specimens are 
presented in Table 3. 
POREX, Fine 
10-20 ~ 
Time Water 
9.1000 
11.1167 
12.8500 
22 
TABLE 2-continued 
250.5556 
249.9119 
249.3742 
250.1976 
249.5267 
2489901 
447.8187 
446.7887 
445.5790 
449.7215 
449.0990 
448.0119 
As seen from these data, the amount of water uptake 
increased linearly until the saturation level was reached. The 
development of hydrophilicity clearly occurred prior to 
observation of any mass loss. and appeared to be dependent 
on the rate of diffusion of the atomic oxygen through the 
porous solid. As the pore size increased, the diffusion rate 
also increased. Also, dyeing of the specimens using a water 
soluble dye showed that a distinct reaction front progressed 
through the porous material. The partially hydrophilicized 
samples had a distributed pore chemistry. the portion ahead 
of the reaction front remaining hydrophobic while the por-
tion behind the reaction front was hydrophobic. 
TABLE 3 
POREX Coarse 
POREX Mediwn (250 I:!!!!~ 
(49-90~ Water 
Exposed Absorbed Time Exposed Water Absorbed TUlle Exposed Absorbed 
Tune (hours) 
0.0000 
1.833 
4.0667 
5.8834 
7.8001 
9.7834 
11.7834 
14.2834 
Tune (hours) 
0.0000 
1.6167 
3.6167 
5.6167 
7.1000 , 
(sec) (% of disc wI.) (sec) (% of disc wI,) (sec) (% of disc wI.) 
5 
10 
15 
20 
30 
40 
50 
70 
90 
120 
180 
300 
600 
700 
TABLE 2 
Sample Weight (mg) 
POREX, Mediwn 
HDPE Sheet (1 mil) (49-90 !JIll) 
Disc #1 Disc #2 Disc #1 Disc #2 
6.8223 6.7433 226.8562 229.1452 
6.4403 6.3288 225.2864 227.5929 
6.1962 6.0763 224.4133 226.7565 
5.9684 5.8701 223.6999 226.0678 
5.7616 5.6614 223.0172 225.3709 
5.5604 5.4508 222.3613 224.6970 
5.3590 5.2480 221.6863 223.9940 
5.1219 5.0195 220.9277 223.2801 
Sample Weight (mg) 
POREX, Fine (10-20 !JIll) POREX, Coarse (250 !JIll) 
Disc #1 Disc #2 Disc #1 Disc #2 
254.0969 253.5941 451.5491 454.2949 
253.0543 252.7013 450.7072 453.0781 
252.4069 252.0329 449.8757 451.7606 
251.7920 251.4103 449.2417 451.1571 
251.2774 250.9041 ...448.5435 450.6771 
1.9 3 5.2 2 4.6 
8.4 5 6.7 4 14.0 
10.4 10 12.1 6 17.3 
11.6 10 12.7 10 25.8 
14.0 15 18.9 15 36.S 
18.0 20 18.9 15 36.S 
20.1 30 34.0 22 47.3 
23.2 40 41.8 40 53.4 
24.3 60 48.0 60 54.1 
32.9 90 64.8 90 52.6 
47.0 120 68.0 
55.7 150 74.3 
65.9 180 75.0 
65.2 210 79.5 
240 82.8 
The foregoing description of the invention is illustrative 
and explanatory thereof. Various changes in the materials, 
apparatus, and particular parts employed will occur to those 
45 skilled in the art. It is intended that all such variations within 
the scope and spirit of the appended claims be embraced 
thereby. 
I claim: 
1. A porous organic polymer solid comprising a hydro-
50 philic interstitial surface formed by a method comprising the 
steps of: 
exposing an exterior surface of the substrate to an oxi-
dizing or reducing gas, containing an oxidizing or 
reducing species selected from atomic oxygen, 
55 hydroxyl and amino radicals, at conditions and for a 
time effective to hydrophilicize an interstitial surface of 
said substrate; and 
60 
65 
recovering a substrate having a hydrophilic interstitial 
surface to a depth spaced from said exterior surface; 
wherein the method further comprises the step of; 
precoating the interstitial surface with an organosiloxane 
that forms a silicon oxide coating during said exposure 
to the Oxidizing gas to inhibit the mass loss from the 
interstitial surface. . 
2. The structure of claim 1 wherein the polymer has a rate 
of mass loss from the interstitial surface exposed to the 
5,935,845 
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oxidizing or reducing species substantially less than a rate of 
hydrophilicization. 
3. The structure of claim. 1 wherein said exposure is of 
limited duration to form a distinct reaction front behind 
which the substrate is hydrophilicized, and in front of which 5 
the substrate remains hydrophobic. 
24 
4. The structure of claim. 1 wherein said exposure is of 
limited duration to form a distinct reaction front which 
passes through the entirety of the polymer material so as 
torender the entire interstitial surface hydrophilic. 
* * * * * 
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